Toroso Investments LLC Purchases 500 Shares of Chemed Co. (NYSE:CHE)

Toroso Investments LLC lifted its position in Chemed Co. (NYSE:CHEFree Report) by 44.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,621 shares of the company’s stock after purchasing an additional 500 shares during the quarter. Toroso Investments LLC’s holdings in Chemed were worth $872,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Janiczek Wealth Management LLC boosted its position in shares of Chemed by 309.1% during the 1st quarter. Janiczek Wealth Management LLC now owns 45 shares of the company’s stock valued at $25,000 after acquiring an additional 34 shares in the last quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its stake in shares of Chemed by 400.0% in the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 75 shares of the company’s stock valued at $40,000 after purchasing an additional 60 shares during the period. Altshuler Shaham Ltd lifted its position in shares of Chemed by 60.8% during the 1st quarter. Altshuler Shaham Ltd now owns 82 shares of the company’s stock worth $44,000 after buying an additional 31 shares during the period. Canada Pension Plan Investment Board bought a new position in shares of Chemed during the 1st quarter worth approximately $46,000. Finally, Benjamin Edwards Inc. grew its position in Chemed by 98.0% in the first quarter. Benjamin Edwards Inc. now owns 99 shares of the company’s stock valued at $53,000 after acquiring an additional 49 shares during the period. 94.25% of the stock is owned by institutional investors.

Chemed Trading Down 0.2 %

CHE opened at $511.13 on Tuesday. Chemed Co. has a 1-year low of $430.16 and a 1-year high of $574.66. The firm has a 50-day moving average price of $519.35 and a two-hundred day moving average price of $532.33. The stock has a market capitalization of $7.71 billion, a PE ratio of 34.08, a PEG ratio of 3.04 and a beta of 0.53.

Chemed (NYSE:CHEGet Free Report) last announced its quarterly earnings data on Wednesday, July 26th. The company reported $4.71 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.38). The firm had revenue of $553.80 million during the quarter, compared to the consensus estimate of $562.54 million. Chemed had a net margin of 10.36% and a return on equity of 34.65%. The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.84 earnings per share. On average, research analysts predict that Chemed Co. will post 19.14 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 5th. Investors of record on Monday, August 14th were issued a $0.40 dividend. This is a positive change from Chemed’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 0.31%. The ex-dividend date was Friday, August 11th. Chemed’s dividend payout ratio is currently 10.67%.

Analyst Ratings Changes

CHE has been the subject of a number of recent analyst reports. upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Wednesday, August 30th. Royal Bank of Canada decreased their price target on Chemed from $610.00 to $576.00 and set an “outperform” rating on the stock in a research report on Monday, July 31st.

View Our Latest Research Report on Chemed

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 4,000 shares of Chemed stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $516.43, for a total transaction of $2,065,720.00. Following the completion of the sale, the chief executive officer now directly owns 115,571 shares of the company’s stock, valued at $59,684,331.53. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 4.03% of the company’s stock.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with's FREE daily email newsletter.